Changeflow GovPing Pharma & Drug Safety ACME UNITED CORPORATION Class II Recall for Alc...
Urgent Enforcement Amended Final

ACME UNITED CORPORATION Class II Recall for Alcohol Hand Wipe

Favicon for changeflow.com FDA: Drug Recalls Class II
Filed March 11th, 2026
Detected March 28th, 2026
Email

Summary

The FDA has initiated a Class II recall for ACME UNITED CORPORATION's Antimicrobial Alcohol Hand Wipe due to CGMP deviations. The recall affects product distributed nationwide in the United States and is currently ongoing.

What changed

The FDA has issued a Class II recall for ACME UNITED CORPORATION's Antimicrobial Alcohol Hand Wipes (Isopropyl Alcohol 70%, NDC 0924-251-00) due to Current Good Manufacturing Practice (CGMP) deviations. The recall, identified by docket number D-0378-2026, is ongoing and impacts product distributed nationwide.

Manufacturers and distributors of this product must immediately cease distribution and implement recall procedures. Compliance officers should review their CGMP adherence, particularly concerning manufacturing processes and quality control, to prevent similar issues. While specific penalties are not detailed, failure to comply with recall orders can result in significant regulatory action and reputational damage.

What to do next

  1. Cease distribution of affected product
  2. Implement recall procedures as per FDA guidelines
  3. Review internal CGMP compliance and quality control processes

Source document (simplified)

ACME UNITED CORPORATION

Drug Recalls (Class II)

← All Drug Recalls (Class II) Class II D-0378-2026 · 20260311 · Ongoing

Product

Antimicrobial Alcohol Hand Wipe, Isopropyl Alcohol 70%, Manufactured for : Custom Packaging Co., Inc, Louisville, KY 4023, NDC 0924-251-00.

Reason for Recall

CGMP Deviations

Distribution

Nationwide within the United States

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 11th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
D-0378-2026
Docket
D-0378-2026

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Manufacturing Product Recall
Threshold
Class II recall
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Product Safety Manufacturing Compliance

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Drug Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.